These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36467087)

  • 61. [Potential pitfalls of anti-VEGF therapy of neovascular age-related macular degeneration].
    Kovalevskaya MA; Pererva OA; Roldugin AA; Kartamyshev EG
    Vestn Oftalmol; 2021; 137(6):149-156. PubMed ID: 34965081
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Glucagon-like peptide 1 receptor agonists and the potential risk of pancreatic carcinoma: a pharmacovigilance study using the FDA Adverse Event Reporting System and literature visualization analysis.
    Cao M; Pan C; Tian Y; Wang L; Zhao Z; Zhu B
    Int J Clin Pharm; 2023 Jun; 45(3):689-697. PubMed ID: 36977858
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Analysis of Spontaneous Postmarket Case Reports Submitted to the FDA Regarding Thromboembolic Adverse Events and JAK Inhibitors.
    Verden A; Dimbil M; Kyle R; Overstreet B; Hoffman KB
    Drug Saf; 2018 Apr; 41(4):357-361. PubMed ID: 29196988
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of Anti-VEGF Therapy on the Disease Progression of Neovascular Age-Related Macular Degeneration: A Systematic Review and Model-Based Meta-Analysis.
    Luu KT; Seal J; Green M; Winskill C; Attar M
    J Clin Pharmacol; 2022 May; 62(5):594-608. PubMed ID: 34783362
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
    Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Electrolyte Disorders Associated with Piperacillin/Tazobactam: A Pharmacovigilance Study Using the FAERS Database.
    Seo H; Kim E
    Antibiotics (Basel); 2023 Jan; 12(2):. PubMed ID: 36830151
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Real-world study of antiresorptive-related osteonecrosis of jaw based on the US food and drug administration adverse event reporting system database.
    Peng J; Wang H; Liu Z; Xu ZL; Wang MX; Chen QM; Wu ML; Ren XL; Liang QH; Liu FP; Ban B
    Front Pharmacol; 2022; 13():1017391. PubMed ID: 36339548
    [No Abstract]   [Full Text] [Related]  

  • 68. Cardiovascular toxicity associated with angiogenesis inhibitors: A comprehensive pharmacovigilance analysis based on the FDA Adverse Event Reporting System database from 2014 to 2021.
    Wang Y; Cui C; Ren X; Dong X; Cui W
    Front Cardiovasc Med; 2022; 9():988013. PubMed ID: 36312283
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Risk of Systemic Adverse Events after Intravitreal Bevacizumab, Ranibizumab, and Aflibercept in Routine Clinical Practice.
    Maloney MH; Payne SR; Herrin J; Sangaralingham LR; Shah ND; Barkmeier AJ
    Ophthalmology; 2021 Mar; 128(3):417-424. PubMed ID: 32781110
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports.
    Hoffman KB; Dimbil M; Tatonetti NP; Kyle RF
    Drug Saf; 2016 Jun; 39(6):561-75. PubMed ID: 26946292
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
    Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007419. PubMed ID: 30325017
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Signal Detection of Adverse Drug Reactions of Cephalosporins Using Data from a National Pharmacovigilance Database.
    Choi JY; Choi JH; Kim MG; Rhie SJ
    Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34063258
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Data mining spontaneous adverse drug event reports for safety signals in Singapore - a comparison of three different disproportionality measures.
    Ang PS; Chen Z; Chan CL; Tai BC
    Expert Opin Drug Saf; 2016 May; 15(5):583-90. PubMed ID: 26996192
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparative Safety Signal Assessment of Hospitalization Associated With the Use of Atypical Antipsychotics.
    Yunusa I; Teng C; Karaye IM; Crounse E; Alsahali S; Maleki N
    Front Psychiatry; 2022; 13():917351. PubMed ID: 35733796
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hepatotoxicity reports in the FDA adverse event reporting system database: A comparison of drugs that cause injury
    Rana P; Aleo MD; Wen X; Kogut S
    Acta Pharm Sin B; 2021 Dec; 11(12):3857-3868. PubMed ID: 35024312
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hematological toxicities in immune checkpoint inhibitors: A pharmacovigilance study from 2014 to 2019.
    Ye X; Hu F; Zhai Y; Qin Y; Xu J; Guo X; Zhuang Y; He J
    Hematol Oncol; 2020 Oct; 38(4):565-575. PubMed ID: 32383782
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Aromatase inhibitors associated osteonecrosis of jaw: signal refining to identify pseudo safety signals.
    Neha R; Beulah E; Anusha B; Vasista S; Stephy C; Subeesh V
    Int J Clin Pharm; 2020 Apr; 42(2):721-727. PubMed ID: 32270377
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System.
    Raschi E; Mazzarella A; Antonazzo IC; Bendinelli N; Forcesi E; Tuccori M; Moretti U; Poluzzi E; De Ponti F
    Target Oncol; 2019 Apr; 14(2):205-221. PubMed ID: 30927173
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Systematic analysis of safety profile for darunavir and its boosted agents using data mining in the FDA Adverse Event Reporting System database.
    Tian X; Yao Y; He G; Jia Y; Wang K; Chen L
    Sci Rep; 2021 Jun; 11(1):12438. PubMed ID: 34127681
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ocular Safety Profile of BRAF and MEK Inhibitors: Data from the World Health Organization Pharmacovigilance Database.
    Mettler C; Monnet D; Kramkimel N; Tréluyer JM; Mouthon L; Brézin A; Dupin N; Valnet-Rabier MB; Chouchana L; Terrier B
    Ophthalmology; 2021 Dec; 128(12):1748-1755. PubMed ID: 34000304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.